New Medical Technologies at startups (July 2009). New companies in the medical technology industry are pursuing technologies to make existing technologies obsolete, expand existing markets, create new markets and otherwise tap into demand for new solutions in healthcare.
New medical technologies represented in specific companies recently added (July 2009) to the Medtech Startups Database:
Pedicle screw replacement [...]
A development emerging out of Tel Aviv’s Sackler School of Medicine, TAU Grows New Blood Vessels To Combat Heart Disease, centers on the ability of injecting a specific protein into oxygen-starved tissue to cause formation of new blood vessels, a development that bodes potential to treat ischemic heart disease, among others.
Perhaps it is due to the [...]
For the purpose of profiling some medtech startups, I was reviewing the state-by-state numbers of companies in our medtech startups database and revealed some interesting concentrations in the data. First, it should be no surprise that California, long having a tradition in this industry, has more medtech companies than any other state.
Concentrations of companies with technologies in [...]
Below is a sampling of recently identified medical technology startups, identified in 2009 (drawn from the Medtech Startups Database).
Company
Product/technology
QFX Technologies, Inc.
External fixation for leg bone fractures.
Axis Surgical Technologies, Inc.
Devices for minimally invasive spine surgery
NuOrtho Surgical, Inc.
Radiofrequency preservation of tissues during orthopedic surgery
Selecta Biosciences, Inc.
Nanoparticle-based immunomodulatory drugs.
EndoMetabolic Solutions, Inc.
Pharmaceutical preparations for treatment of obesity.
AVIDAL Vascular GmbH
Drug-eluting [...]
New medical technology development is active and driving the formation of many new medical technology companies. In MedMarket Diligence’s tracking of medtech startups (with an emphasis on medical device technologies as well as those complementary to, or directly competing with, them), over 280 companies have been founded since early 2006. Below is a distribution of [...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial.
Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective as [...]
Below are the products/technologies at recently identified medtech startups:
Company
City
Country
Founded
Product/Technology
Checkpoint Surgical, LLC
Cleveland, OH
USA
2008
Intraoperative nerve location and protection device.
DiFUSION Technologies, Inc.
Austin, TX
USA
2008
Medical device to prevent surgical site infections in orthopedic and spinal surgeries.
FHL Innovations, LLC
Fredericksburg, VA
USA
2007
Surgical dressings
GS Medical Co. Ltd.
Seoul
Korea
2007
Spinal implant manufacturer
IQ Medical Devices, LLC
Belmont, MA
USA
2006
Surgical irrigation and retraction systems.
Millennium Medical Technologies, Inc.
La Verne, CA
USA
2006
Autologous [...]
This article in Forbes is interesting for its stranglehold on the obvious.
Noting that the shares of surgical device maker, Cardica, and gene therapy device maker, Cardium Therapeutics, have fallen of late, making them potential acquisition targets which, of course, virtually all med-tech companies are anyway. In fact, and to give Forbes credit, their point [...]
There is certainly the possibility (despite my doubts) that the current economic slowdown in global markets will have major effects on the medical technology industry. One simply cannot deny that there is simply less VC or other cash floating around that might be put to medtech investment. And maybe, as has occurred in [...]
In the Medtech Startups Database, we identify newly formed medical technology companies and capture as much data as possible on these sometimes secretive, “stealthy” companies. The companies we include are those that are predominantly, though not exclusively, device-intensive, but may also include those developing drug-device hybrids, biomaterials, biotech, drug or other technologies that are evolving [...]
Contact:
